FI932826A0 - DNA-fragment som kodar underenheter av transferrinreseptor av Neisseria meningitidis-bakerien - Google Patents

DNA-fragment som kodar underenheter av transferrinreseptor av Neisseria meningitidis-bakerien

Info

Publication number
FI932826A0
FI932826A0 FI932826A FI932826A FI932826A0 FI 932826 A0 FI932826 A0 FI 932826A0 FI 932826 A FI932826 A FI 932826A FI 932826 A FI932826 A FI 932826A FI 932826 A0 FI932826 A0 FI 932826A0
Authority
FI
Finland
Prior art keywords
dna fragment
transferrin receptor
neisseria meningitidis
coded under
meningitidis bacteria
Prior art date
Application number
FI932826A
Other languages
English (en)
Other versions
FI932826A (fi
Inventor
Eric Jacobs
Michele Legrain
Veronique Mazarin
Bernadette Bouchon-Theisen
Anthony B Shryvers
Marie-Aline Bloch
Original Assignee
Pasteur Merieux Serums Vacc
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc, Transgene Sa filed Critical Pasteur Merieux Serums Vacc
Publication of FI932826A0 publication Critical patent/FI932826A0/fi
Publication of FI932826A publication Critical patent/FI932826A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70582CD71
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI932826A 1992-06-19 1993-06-18 Dna-fragment som kodar underenheter av transferrinreseptor av neisseria meningitidis-bakerien FI932826A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9207493A FR2692592B1 (fr) 1992-06-19 1992-06-19 Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.

Publications (2)

Publication Number Publication Date
FI932826A0 true FI932826A0 (fi) 1993-06-18
FI932826A FI932826A (fi) 1993-12-20

Family

ID=9430946

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932826A FI932826A (fi) 1992-06-19 1993-06-18 Dna-fragment som kodar underenheter av transferrinreseptor av neisseria meningitidis-bakerien

Country Status (12)

Country Link
US (2) US6028049A (fi)
EP (1) EP0586266B1 (fi)
JP (1) JPH06277066A (fi)
AT (1) ATE242810T1 (fi)
AU (1) AU679911B2 (fi)
CA (1) CA2098448A1 (fi)
DE (1) DE69333036T2 (fi)
ES (1) ES2199938T3 (fi)
FI (1) FI932826A (fi)
FR (1) FR2692592B1 (fi)
HU (1) HU219267B (fi)
NO (1) NO932222L (fi)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3532563B2 (ja) 1990-08-23 2004-05-31 ザ ユニバーシティー オブ ノースカロライナ アット チャペル ヒル Neisseria gonorrhoeaeおよびNeisseria meningitidis由来トランスフェリン結合蛋白質
US5912336A (en) * 1990-08-23 1999-06-15 University Of North Carolina At Chapel Hill Isolated nucleic acid molecules encoding transferrin binding proteins from Neisseria gonorrhoeae and Neisseria meningitidis
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
CA2173142C (en) * 1993-10-01 2000-11-14 Thomas Bosselmann Method and device for measuring an electrical alternating quantity with temperature compensation
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
FR2724936A1 (fr) * 1994-09-22 1996-03-29 Pasteur Merieux Serums Vacc Recepteur lactoferrine d'helicobacter
WO1997013784A1 (fr) * 1995-10-09 1997-04-17 Pasteur Merieux Serums Et Vaccins Recepteur lactoferrine d'helicobacter
FR2739624B1 (fr) * 1995-10-10 1997-12-05 Pasteur Merieux Serums Vacc Nouvelle sous-unite tbp2 de neisseria meningitidis
US6290970B1 (en) * 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
US6610506B1 (en) 1995-12-01 2003-08-26 University Technologies International, Inc. Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same
FR2767060B1 (fr) * 1997-08-07 2000-02-11 Pasteur Merieux Serums Vacc Vaccin meningocoque comportant la valence de souche bz83
ATE344325T1 (de) * 1997-08-15 2006-11-15 Univ Utrecht Neisseria lactoferrin-bindendes protein
BR9910089A (pt) 1998-05-01 2004-06-08 Chiron Corp Composições e antìgenos de neisseria meningitidis
US10967045B2 (en) 1998-11-02 2021-04-06 Secretary of State for Health and Social Care Multicomponent meningococcal vaccine
US6391316B1 (en) 1999-03-10 2002-05-21 University Of Saskatchewan Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use
ES2397918T3 (es) 1999-04-30 2013-03-12 Novartis Vaccines And Diagnostics S.R.L. Antígenos Neisseriales conservados
CN100338218C (zh) * 1999-05-19 2007-09-19 启龙股份公司 组合式奈瑟球菌组合物
AU6490500A (en) * 1999-07-16 2001-02-05 Gerald R. Potts Methods and systems for dynamic force measurement
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
US6388434B1 (en) 2000-01-17 2002-05-14 Bechtel Bwxt Idaho, Llc Electro-optic high voltage sensor
EP2270030B1 (en) * 2000-02-28 2012-05-23 Novartis Vaccines and Diagnostics S.r.l. Heterologous expression of Neisserial proteins
GB0007433D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Recombinant transferrin binding proteins
US20030232055A1 (en) * 2000-07-31 2003-12-18 Ruslan Medzhitov Innate immune system-directed vaccines
US20030175287A1 (en) * 2001-01-03 2003-09-18 Yale University Innate immune system-directed vaccines
US7138267B1 (en) 2001-04-04 2006-11-21 Epicentre Technologies Corporation Methods and compositions for amplifying DNA clone copy number
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
EP2390308A1 (en) 2002-02-25 2011-11-30 Vaxiion Therapeutics Inc Minicell compositions and methods
TWI360424B (en) * 2002-08-02 2012-03-21 Glaxosmithkline Biolog Sa Vaccine
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
PT1549338E (pt) 2002-10-11 2011-02-23 Novartis Vaccines & Diagnostic Vacinas polipeptídicas para protecção alargada contra linhagens meningocócicas hipervirulentas
JP2006504801A (ja) 2002-11-01 2006-02-09 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 乾燥方法
PL1670506T3 (pl) 2003-10-02 2013-04-30 Novartis Ag Płynne szczepionki przeciw wielu grupom serologicznym meningokoków
ES2346314T3 (es) 2003-10-02 2010-10-14 Glaxosmithkline Biolog Sa Antigenos de b. pertussis y uso de los mismos en vacunacion.
US7628995B2 (en) 2003-12-23 2009-12-08 Glaxosmithkline Biologicals S.A. Outer membrane vesicles and uses thereof
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
JP5275983B2 (ja) 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
AU2010247254A1 (en) 2009-05-14 2012-01-12 Sanofi Pasteur Menigococcus vaccine containing lipooligosaccharide (LOS) from modified strains of L6 immunotype Neisseria meningitidis
EP2429658B1 (fr) * 2009-05-14 2016-04-20 Sanofi Pasteur Procédé pour adjuver le lipopolysaccharide (LPS) des bactéries à gram-négatif
EP2544713A1 (en) 2010-03-10 2013-01-16 GlaxoSmithKline Biologicals S.A. Immunogenic composition
WO2012032498A2 (en) 2010-09-10 2012-03-15 Novartis Ag Developments in meningococcal outer membrane vesicles
TWI689314B (zh) 2010-11-30 2020-04-01 建南德克公司 低親和力血腦障壁受體抗體及其用途
CN104602704B (zh) 2012-06-14 2019-08-06 诺华股份有限公司 针对血清组x脑膜炎球菌的疫苗
EA037909B1 (ru) 2013-12-02 2021-06-04 Инжиниред Антидженз Инк. Иммуногенные композиции и вакцины, полученные из рецепторных белков поверхности бактерий

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
JP3532563B2 (ja) * 1990-08-23 2004-05-31 ザ ユニバーシティー オブ ノースカロライナ アット チャペル ヒル Neisseria gonorrhoeaeおよびNeisseria meningitidis由来トランスフェリン結合蛋白質
FR2682114B1 (fr) * 1991-10-03 1996-02-23 Pasteur Merieux Serums Vacc Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.

Also Published As

Publication number Publication date
FR2692592A1 (fr) 1993-12-24
HU219267B (en) 2001-03-28
EP0586266A1 (fr) 1994-03-09
AU679911B2 (en) 1997-07-17
US6028049A (en) 2000-02-22
FR2692592B1 (fr) 1995-03-31
HUT68443A (en) 1995-06-28
JPH06277066A (ja) 1994-10-04
NO932222D0 (no) 1993-06-16
HU9301791D0 (en) 1993-10-28
CA2098448A1 (en) 1993-12-20
EP0586266B1 (fr) 2003-06-11
NO932222L (no) 1993-12-20
DE69333036D1 (de) 2003-07-17
AU4009893A (en) 1993-12-23
ES2199938T3 (es) 2004-03-01
ATE242810T1 (de) 2003-06-15
DE69333036T2 (de) 2004-05-13
FI932826A (fi) 1993-12-20
US6326350B1 (en) 2001-12-04

Similar Documents

Publication Publication Date Title
FI932826A0 (fi) DNA-fragment som kodar underenheter av transferrinreseptor av Neisseria meningitidis-bakerien
AU5534996A (en) Antibody purification by low-pH hydrophobic interaction chromatography
ATE361362T1 (de) Gene von moraxella, die für transferrin- rezeptoren kodieren.
SE8601325D0 (sv) Sett att producera ett immunglobulinbindande protein samt medel for detta
HU9303182D0 (en) Truncated forms of the hepatocite growth factor (hgf) receptor pharmaceutical compositions containing them and process for production off them
NO985848L (no) Nytt protein og fremgangsmÕte for fremstilling av dette
DK0798378T3 (da) Estrogen-receptor
FR2852311B1 (fr) Fils de verre aptes a renforcer des matieres organiques et/ou inorganiques, procede de fabrication desdits fils de verre et composition utilisee
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
FI101542B1 (fi) Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi
HK1064683A1 (en) Receptor of the edb fibronectin domains (II)
DK1334096T3 (da) Friedel-Craft-fremgangsmåde til fremstillingen af thioxanthoner
EP0643076A4 (en) NOVEL PEPTIDE HAVING RECEPTOR ACTIVITY AND DNA ENCODING THE PEPTIDE.
ATE202798T1 (de) D-aminosäure-oxidase kodierendes dns-fragment
ES2091458T3 (es) Clonacion de un nuevo miembro de la familia de los receptores de factores de crecimiento fibroblastico (fgf).
NO20030640D0 (no) Fremgangsmåte for fremstilling av bicykliske forbindelser og mellomprodukter derfor
FI921356A (fi) Somatostatinreceptor
NO20011961D0 (no) PRV-1-genet og anvendelsen av dette
ES2151615T3 (es) Procedimiento para la obtencion de pirazoles.
DE69415001D1 (de) Prozess und zwischenverbindungen zur herstellung von blaettchen glycoprotein iib/iiia hemmern
DE69431441D1 (de) Trizyklische verbindungen mit affinität für den 5-ht1a rezeptor
EP1471062A4 (en) EPOXYL FULLERENE AND PROCESS FOR PRODUCING THE SAME
SE0000177D0 (sv) Protein purification II